A Novel Method for Volumetric MRI Response Assessment of Enhancing Brain Tumors

被引:40
作者
Kanaly, Charles W. [1 ]
Ding, Dale [2 ]
Mehta, Ankit I. [1 ]
Waller, Anthony F. [3 ]
Crocker, Ian [3 ]
Desjardins, Annick [4 ]
Reardon, David A. [1 ]
Friedman, Allan H. [1 ]
Bigner, Darell D. [5 ]
Sampson, John H. [1 ,5 ]
机构
[1] Duke Univ, Med Ctr, Div Neurosurg, Dept Surg, Durham, NC 27710 USA
[2] Univ Virginia, Dept Neurosurg, Charlottesville, VA USA
[3] Emory Univ, Dept Radiat Oncol, Atlanta, GA 30322 USA
[4] Duke Univ, Med Ctr, Dept Neurol, Durham, NC USA
[5] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA
来源
PLOS ONE | 2011年 / 6卷 / 01期
基金
美国国家卫生研究院;
关键词
HIGH-GRADE GLIOMAS; FUNCTIONAL DIFFUSION MAP; PROGRESSION-FREE SURVIVAL; MALIGNANT GLIOMA; CONCOMITANT RADIOCHEMOTHERAPY; IMAGING BIOMARKER; SOLID TUMORS; END-POINT; PHASE-II; CRITERIA;
D O I
10.1371/journal.pone.0016031
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Current radiographic response criteria for brain tumors have difficulty describing changes surrounding postoperative resection cavities. Volumetric techniques may offer improved assessment, however usually are time-consuming, subjective and require expert opinion and specialized magnetic resonance imaging (MRI) sequences. We describe the application of a novel volumetric software algorithm that is nearly fully automated and uses standard T1 pre- and post-contrast MRI sequences. T1-weighted pre- and post-contrast images are automatically fused and normalized. The tumor region of interest is grossly outlined by the user. An atlas of the nasal mucosa is automatically detected and used to normalize levels of enhancement. The volume of enhancing tumor is then automatically calculated. We tested the ability of our method to calculate enhancing tumor volume with resection cavity collapse and when the enhancing tumor is obscured by subacute blood in a resection cavity. To determine variability in results, we compared narrowly-defined tumor regions with tumor regions that include adjacent meningeal enhancement and also compared different contrast enhancement threshold levels used for the automatic calculation of enhancing tumor volume. Our method quantified enhancing tumor volume despite resection cavity collapse. It detected tumor volume increase in the midst of blood products that incorrectly caused decreased measurements by other techniques. Similar trends in volume changes across scans were seen with inclusion or exclusion of meningeal enhancement and despite different automated thresholds for tissue enhancement. Our approach appears to overcome many of the challenges with response assessment of enhancing brain tumors and warrants further examination and validation.
引用
收藏
页数:8
相关论文
共 43 条
[1]   Time course of imaging changes of GBM during extended bevacizumab treatment [J].
Ananthnarayan, Suchitra ;
Bahng, Jennie ;
Roring, James ;
Nghiemphu, Phioanh ;
Lai, Albert ;
Cloughesy, Timothy ;
Pope, Whitney B. .
JOURNAL OF NEURO-ONCOLOGY, 2008, 88 (03) :339-347
[2]   The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme [J].
Ballman, Karla V. ;
Buckner, Jan C. ;
Brown, Paul D. ;
Giannini, Caterina ;
Flynn, Patrick J. ;
LaPlant, Betsy R. ;
Jaeckle, Kurt A. .
NEURO-ONCOLOGY, 2007, 9 (01) :29-38
[3]   Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology [J].
Brandes, Alba A. ;
Tosoni, Alicia ;
Spagnolli, Federica ;
Frezza, Giarnpiero ;
Leonardi, Marco ;
Calbucci, Fabio ;
Franceschi, Enrico .
NEURO-ONCOLOGY, 2008, 10 (03) :361-367
[4]   MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients [J].
Brandes, Alba A. ;
Franceschi, Enrico ;
Tosoni, Alicia ;
Blatt, Valeria ;
Pession, Annalisa ;
Tallini, Giovanni ;
Bertorelle, Roberta ;
Bartolini, Stefania ;
Calbucci, Fabio ;
Andreoli, Alvaro ;
Frezza, Giampiero ;
Leonardi, Marco ;
Spagnolli, Federica ;
Ermani, Mario .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (13) :2192-2197
[5]   Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas [J].
Brandsma, Dieto ;
Stalpers, Lukas ;
Taal, Walter ;
Sminia, Peter ;
van den Bent, Martinj .
LANCET ONCOLOGY, 2008, 9 (05) :453-461
[6]   Correlation of positron emission tomography standard uptake value and pathologic specimen size in cancer of the head and neck [J].
Burri, Ryan J. ;
Rangaswamy, Balasubramanya ;
Kostakoglu, Lale ;
Hoch, Benjamin ;
Genden, Eric M. ;
Som, Peter M. ;
Kao, Johnny .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (03) :682-688
[7]   Automatic tumor segmentation using knowledge-based techniques [J].
Clark, MC ;
Hall, LO ;
Goldgof, DB ;
Velthuizen, R ;
Murtagh, FR ;
Silbiger, MS .
IEEE TRANSACTIONS ON MEDICAL IMAGING, 1998, 17 (02) :187-201
[8]   MRI measurement of brain tumor response: Comparison of visual metric and automatic segmentation [J].
Clarke, LP ;
Velthuizen, RP ;
Clark, M ;
Gaviria, J ;
Hall, L ;
Goldgof, D ;
Murtagh, R ;
Phuphanich, S ;
Brem, S .
MAGNETIC RESONANCE IMAGING, 1998, 16 (03) :271-279
[9]   Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression [J].
de Wit, MCY ;
de Bruin, HG ;
Eijkenboom, W ;
Smitt, PAES ;
van den Bent, MJ .
NEUROLOGY, 2004, 63 (03) :535-537
[10]  
Dempsey MF, 2005, AM J NEURORADIOL, V26, P770